作为系统性红斑狼的潜在治疗标,JAK抑制是一种潜在的治疗标
Georgia-Savina Moysidou1, Athanasia Dara2
1National and Kapodistrian University of Athens, Faculty of Medicine, Athens, Greece; Inflammation and Autoimmunity Lab, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.
Mediterranean journal of rheumatology
|May 17, 2024
概括
简氏激酶 (JAK) 抑制剂通过向参与免疫耐受性的JAK/STAT通路来治疗全身性红斑狼 (SLE) 是有前途的. 临床试验表明SLE患者的疗效和安全性.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 简氏激酶 (JAK) /信号传感器和转录激活器 (STATs) 途径对于免疫耐受性至关重要.
- JAK/STAT通路的失调有助于自身免疫,炎症和过敏性疾病.
- 雅克抑制剂 (JAKinibs) 已被批准用于类风湿性关节炎,牛皮性关节炎和性脊柱炎.
研究的目的:
- 审查针对系统性红斑狼 (SLE) 的JAK抑制剂的理由.
- 总结有关SLE患者中JAK抑制剂的疗效和安全性的当前临床数据.
主要方法:
- 审查正在进行的临床试验和发表的关于SLE中JAK抑制剂的文献.
- 从涉及托法西替尼,巴里西替尼和德克拉瓦西替尼在SLE的研究中获得的疗效和安全数据的分析.
主要成果:
- 在众多SLE试验中,JAK抑制剂正在被评估.
- 托法西提尼布,巴里西提尼布和德乌克拉维西提尼布在SLE中表现出有希望的结果.
- 目前的数据表明,与SLE中JAK抑制剂相关的重大安全问题并不存在.
结论:
- 用JAK抑制剂向JAK/STAT通路是SLE.一个可行的治疗策略.
- 雅克抑制剂对SLE患者来说是一个有前途的治疗选择,在临床研究中观察到有利的疗效和安全性.
关键词:
杰克·杰克是什么意思抑制抑制抑制的抑制作用这是潜在的潜在潜力.系统性红血性狼 (Systemic Lupus Erythematosus) 是一种全身性狼.目标目标目标目标目标目标目标.治疗治疗治疗治疗治疗治疗更多相关视频
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
601
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
601
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
131
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
131
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Enzyme Inhibition
78.3K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.3K
Open Angle Glaucoma: Treatment
432
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
432


